Cannabis can cause depression and anxiety in teenagers

NewsGuard 100/100 Score

Canadian teenagers are among the largest consumers of cannabis worldwide. The damaging effects of this illicit drug on young brains are worse than originally thought, according to new research by Dr. Gabriella Gobbi, a psychiatric researcher from the Research Institute of the McGill University Health Centre. The new study, published in Neurobiology of Disease, suggests that daily consumption of cannabis in teens can cause depression and anxiety, and have an irreversible long-term effect on the brain.

"We wanted to know what happens in the brains of teenagers when they use cannabis and whether they are more susceptible to its neurological effects than adults," explained Dr. Gobbi, who is also a professor at McGill University. Her study points to an apparent action of cannabis on two important compounds in the brain - serotonin and norepinephrine - which are involved in the regulation of neurological functions such as mood control and anxiety.

"Teenagers who are exposed to cannabis have decreased serotonin transmission, which leads to mood disorders, as well as increased norepinephrine transmission, which leads to greater long-term susceptibility to stress," Dr. Gobbi stated.

Previous epidemiological studies have shown how cannabis consumption can affect behaviour in some teenagers. "Our study is one of the first to focus on the neurobiological mechanisms at the root of this influence of cannabis on depression and anxiety in adolescents," confirmed Dr. Gobbi. It is also the first study to demonstrate that cannabis consumption causes more serious damage during adolescence than adulthood.

Source: THE MONTREAL CHILDREN'S HOSPITAL

Source: MCGILL UNIVERSITY HEALTH CENTRE

Source:

THE MONTREAL CHILDREN'S HOSPITAL FOUNDATION

Comments

  1. Neurofreak Neurofreak United States says:

    This PR blurb is amazingly disingenuous. The study was done on adolescent rats, not humans, and did not even involve marijuana, but instead a synthetic marijuana analogue that has both a higher for CB1 receptors than marijuana does, and also happens to be structurally quite different.

    This isn't to say that theres anything wrong with rat studies, or that inferences can't be made from chemical analogues but to say that "y causes x" is an oversimplification that comes pretty close to just being deceitful.

    I go into a little more elaborate detail about this study at my blog at http://www.neurointerests.com/?p=187

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Depression linked to chronic pain: Variability shown across patient characteristics